摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(1,1-dimethylethyl)-3-{[4-(1,1,-dimethylethyl)phenyl]methyl}-2,4,6(1H,3H,5H)-pyrimidinetrione | 960540-88-9

中文名称
——
中文别名
——
英文名称
1-(1,1-dimethylethyl)-3-{[4-(1,1,-dimethylethyl)phenyl]methyl}-2,4,6(1H,3H,5H)-pyrimidinetrione
英文别名
1-(1,1-Dimethylethyl)-{[4-(1,1-dimethylethyl)phenyl]methyl}-2,4,6(1H,3H,5H)-pyrimidinetrione;1-tert-butyl-3-[(4-tert-butylphenyl)methyl]-1,3-diazinane-2,4,6-trione
1-(1,1-dimethylethyl)-3-{[4-(1,1,-dimethylethyl)phenyl]methyl}-2,4,6(1H,3H,5H)-pyrimidinetrione化学式
CAS
960540-88-9
化学式
C19H26N2O3
mdl
——
分子量
330.427
InChiKey
CPLLRPVADNKIME-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    24
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    57.7
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

点击查看最新优质反应信息

文献信息

  • PROLYL HYDROXYLASE INHIBITORS
    申请人:Duffy Kevin J.
    公开号:US20100113444A1
    公开(公告)日:2010-05-06
    The invention described herein relates to certain pyrimidinetrione N-substituted glycine derivatives of formula (I), (I) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.
    本发明涉及以下化学式(I)的某些嘧啶三酮N-取代甘氨酸衍生物,其为HIF脯氨酸羟化酶的拮抗剂,并且对于治疗受益于抑制该酶的疾病,贫血是其中之一的例子。
  • Prolyl hydroxylase inhibitors
    申请人:GlaxoSmithKline LLC
    公开号:US08815884B2
    公开(公告)日:2014-08-26
    The invention described herein relates to certain pyrimidinetrione N-substituted glycine derivatives of formula (I) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.
    本发明涉及某些嘧啶三酮N-取代甘氨酸衍生物的公式(I),其为HIF脯氨酸羟化酶的拮抗剂,并且适用于治疗受益于抑制该酶的疾病,贫血就是其中一个例子。
  • Prolyl Hydroxylase Inhibitors
    申请人:GlaxoSmithKline, LLC
    公开号:US20180305323A1
    公开(公告)日:2018-10-25
    The invention described herein relates to certain pyrimidinetrione N-substituted glycine derivatives of formula (I) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.
  • US8324208B2
    申请人:——
    公开号:US8324208B2
    公开(公告)日:2012-12-04
  • US8557834B2
    申请人:——
    公开号:US8557834B2
    公开(公告)日:2013-10-15
查看更多